CVE-2018-14787

Description

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Vendor Advisory philips.com
Affected: Philips IntelliSpace Cardiovascular (ISCV) products
Published at:
Updated at:

References

Link Tags
https://www.usa.philips.com/healthcare/about/customer-support/product-security vendor advisory
https://ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 third party advisory us government resource

Frequently Asked Questions

What is the severity of CVE-2018-14787?
CVE-2018-14787 has been scored as a high severity vulnerability.
How to fix CVE-2018-14787?
To fix CVE-2018-14787, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-14787 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-14787 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-14787?
CVE-2018-14787 affects Philips IntelliSpace Cardiovascular (ISCV) products.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.